134 related articles for article (PubMed ID: 29766794)
41. Pretreatment with melatonin exerts anti-inflammatory effects against ischemia/reperfusion injury in a rat middle cerebral artery occlusion stroke model.
Pei Z; Cheung RT
J Pineal Res; 2004 Sep; 37(2):85-91. PubMed ID: 15298666
[TBL] [Abstract][Full Text] [Related]
42. Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model.
Shuaib A; Xu Wang C; Yang T; Noor R
Stroke; 2002 Dec; 33(12):3033-7. PubMed ID: 12468809
[TBL] [Abstract][Full Text] [Related]
43. C-Phycocyanin protects SH-SY5Y cells from oxidative injury, rat retina from transient ischemia and rat brain mitochondria from Ca2+/phosphate-induced impairment.
Marín-Prida J; Pentón-Rol G; Rodrigues FP; Alberici LC; Stringhetta K; Leopoldino AM; Naal Z; Polizello AC; Llópiz-Arzuaga A; Rosa MN; Liberato JL; Santos WF; Uyemura SA; Pentón-Arias E; Curti C; Pardo-Andreu GL
Brain Res Bull; 2012 Dec; 89(5-6):159-67. PubMed ID: 22982368
[TBL] [Abstract][Full Text] [Related]
44. Protective effects of allicin against ischemic stroke in a rat model of middle cerebral artery occlusion.
Zhang B; Li F; Zhao W; Li J; Li Q; Wang W
Mol Med Rep; 2015 Sep; 12(3):3734-3738. PubMed ID: 26045182
[TBL] [Abstract][Full Text] [Related]
45. Neuroprotective effects of Huang-Lian-Jie-Du-Decoction on ischemic stroke rats revealed by (1)H NMR metabolomics approach.
Wang PR; Wang JS; Yang MH; Kong LY
J Pharm Biomed Anal; 2014 Jan; 88():106-16. PubMed ID: 24051274
[TBL] [Abstract][Full Text] [Related]
46. The Beneficial Effects of Raffinee in Permanent Occulted Stroke Mice.
Chiu CC; Lin JM; Wu LY; Hsu TC; Tzang BS
J Med Food; 2019 Dec; 22(12):1226-1234. PubMed ID: 31545135
[TBL] [Abstract][Full Text] [Related]
47. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of liposome-encapsulated hemoglobin in a rat model of cerebral ischemia.
Kaneda S; Ishizuka T; Sekiguchi A; Morimoto K; Kasukawa H
Artif Organs; 2014 Aug; 38(8):650-5. PubMed ID: 25132081
[TBL] [Abstract][Full Text] [Related]
49. Bu Yang Huan Wu decoction prevents reperfusion injury following ischemic stroke in rats via inhibition of HIF-1 α, VEGF and promotion β-ENaC expression.
Chen ZZ; Gong X; Guo Q; Zhao H; Wang L
J Ethnopharmacol; 2019 Jan; 228():70-81. PubMed ID: 30218809
[TBL] [Abstract][Full Text] [Related]
50. Delayed 2-h post-stroke administration of R18 and NA-1 (TAT-NR2B9c) peptides after permanent and/or transient middle cerebral artery occlusion in the rat.
Milani D; Cross JL; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
Brain Res Bull; 2017 Oct; 135():62-68. PubMed ID: 28964774
[TBL] [Abstract][Full Text] [Related]
51. Enhanced protection by melatonin and meloxicam combination in a middle cerebral artery occlusion model of acute ischemic stroke in rat.
Gupta YK; Chaudhary G; Sinha K
Can J Physiol Pharmacol; 2002 Mar; 80(3):210-7. PubMed ID: 11991232
[TBL] [Abstract][Full Text] [Related]
52. Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient neuroprotection against ischemic stroke.
Yu G; Hess DC; Borlongan CV
Brain Res; 2004 Aug; 1018(1):32-7. PubMed ID: 15262202
[TBL] [Abstract][Full Text] [Related]
53. Beneficial Effects of Delayed P7C3-A20 Treatment After Transient MCAO in Rats.
Loris ZB; Hynton JR; Pieper AA; Dietrich WD
Transl Stroke Res; 2018 Apr; 9(2):146-156. PubMed ID: 28842830
[TBL] [Abstract][Full Text] [Related]
54. Synergistic Neuroprotection by a PAF Antagonist Plus a Docosanoid in Experimental Ischemic Stroke: Dose-Response and Therapeutic Window.
Reid MM; Obenaus A; Mukherjee PK; Khoutorova L; Roque CR; Petasis NA; Oria RB; Belayev L; Bazan NG
J Stroke Cerebrovasc Dis; 2022 Aug; 31(8):106585. PubMed ID: 35717719
[TBL] [Abstract][Full Text] [Related]
55. Epigallocatechin Gallate Extends the Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment in Ischemic Rats.
You YP
J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):990-7. PubMed ID: 26851971
[TBL] [Abstract][Full Text] [Related]
56. Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment.
Ding Y; Zhou Y; Lai Q; Li J; Gordon V; Diaz FG
Brain Res; 2001 Oct; 915(2):210-7. PubMed ID: 11595210
[TBL] [Abstract][Full Text] [Related]
57. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability.
Cui L; Zhang X; Yang R; Wang L; Liu L; Li M; Du W
Brain Res; 2010 Apr; 1325():164-73. PubMed ID: 20167207
[TBL] [Abstract][Full Text] [Related]
58. Pioglitazone Confers Neuroprotection Against Ischemia-Induced Pyroptosis due to its Inhibitory Effects on HMGB-1/RAGE and Rac1/ROS Pathway by Activating PPAR-ɤ.
Xia P; Pan Y; Zhang F; Wang N; Wang E; Guo Q; Ye Z
Cell Physiol Biochem; 2018; 45(6):2351-2368. PubMed ID: 29554649
[TBL] [Abstract][Full Text] [Related]
59. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
[TBL] [Abstract][Full Text] [Related]
60. Neanthes japonica (Iznka) fibrinolytic enzyme reduced cerebral infarction, cerebral edema and increased antioxidation in rat models of focal cerebral ischemia.
Wang SH; Li Q; Deng ZH; Ji X; Jiang X; Ge X; Bo QQ; Cui JY; Zhang LZ; Liu JK; Hong M
Neurosci Lett; 2011 Feb; 489(1):16-9. PubMed ID: 21129442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
